详情页 - 四川省肿瘤医院知识库

当前位置：首页 > 详情页

68Ga-FAPI-04 Versus 18F-FDG PET/CT in a Case of Xanthogranulomatous Cholecystitis

文献详情

资源类型：

Pubmed体系：

作者：

机构： [1]Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University. [2]Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province. [3]Laboratory for Targeted Radiopharmaceuticals Creation. [4]Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China.

出处：

DOI：

ISSN：

关键词： 18F-FDG 68Ga-FAPI PET/CT xanthogranulomatous cholecystitis

摘要：

Xanthogranulomatous cholecystitis (XGC) is an uncommon inflammatory disease of the gallbladder. We report a case of XGC with elevated activity of 18F-FDG and 68Ga-FAPI (fibroblast activating protein inhibitor), which mimics malignancy. Our case suggests that XGS should be considered in the differential diagnosis of cancer-like gallbladder lesions with increased 68Ga-FAPI uptake.Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2025]版：

大类 | 3 区医学

小类 | 3 区核医学

最新[2025]版：

大类 | 3 区医学

小类 | 3 区核医学

第一作者：

第一作者机构： [1]Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University. [2]Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province. [3]Laboratory for Targeted Radiopharmaceuticals Creation. [4]Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China.

共同第一作者：

通讯作者：

通讯机构： [1]Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University. [2]Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province. [3]Laboratory for Targeted Radiopharmaceuticals Creation. [4]Institute of Nuclear Medicine, Southwest Medical University, Luzhou, Sichuan, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]68Ga]Ga-FAPI PET/CT in brain tumors: comparison with [18F]F-FDG PET/CT [2]Head-to-head comparison of 18F-FDG and 68Ga-FAPI PET/CT in common gynecological malignancies [3]18 F-FDG PET/CT Versus 68 Ga-FAPI PET/CT in a Case of Isolated Nodal-Type Follicular Dendritic Cell Sarcoma [4]A pilot study of [68Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma [5]The additional role of [68Ga]Ga-FAPI-04 PET/CT in patients with unknown primary lesion with a negative or equivocal [18F]FDG [6]Comparison of [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT for detection of bone metastases of lung cancer [7]Prospective comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT for tumor staging in nasopharyngeal carcinoma [8]Comparison of Diagnostic Efficacy of [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT for Staging and Restaging of Gastric Cancer [9]Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Patients With Newly Diagnosed Non-Small Cell Lung Cancer [10]Potential utility of [68Ga]DOTA-FAPI-04 as a broad-spectrum benign disease imaging agent-comparison with [18F]FDG and [99mTc]MDP